Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-11-19
1994-10-25
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424422, 424423, 514937, 530357, 530427, 530842, 623 11, 623901, A61F 202, A61K 3712, C07K 302
Patent
active
053589351
ABSTRACT:
The present invention is a new nonantigenic keratinous protein material that may be used as a number of purposes, including correction of soft tissue deficiencies and the creation of biomedical implants and implant coatings. The present invention also includes processes for using the nonantigenic keratinous protein material for soft tissue augmentation, creating implants, and the coating of biocompatible implants. The nonantigenic keratinous protein material can be formed by obtaining nonantigenic keratinous protein and processing it to a powder form. If hair from the recipient or a compatible doner is used, it is bleached and rinsed, then dried and chopped into about 0.25 inch pieces. The keratinous protein is then homogenized in a solvent to a particular size generally in the range of about 0.1 to about 500 .mu.m. The particles are then ultrasonicated in a solvent. Afterwards, the solvent is evaporated, and the powdered protein is sterilized and suspended in a sterile bioinert solvent to create a protein colloid at a solids concentrations suitable for injection.
REFERENCES:
patent: 1214299 (1917-01-01), Grosvenor et al.
patent: 3699969 (1972-10-01), Allen
patent: 4021522 (1977-05-01), Daniel
patent: 4140537 (1979-02-01), Luck et al.
patent: 4233360 (1980-11-01), Luck et al.
patent: 4250139 (1981-02-01), Luck et al.
patent: 4424208 (1984-01-01), Wallace et al.
patent: 4481001 (1984-11-01), Graham et al.
patent: 4557764 (1985-12-01), Chu
patent: 4582640 (1986-04-01), Smestad et al.
patent: 4642117 (1987-02-01), Nguyen et al.
patent: 4655980 (1987-04-01), Chu
patent: 4725671 (1988-02-01), Chu et al.
patent: 4795467 (1989-01-01), Piez et al.
patent: 4803075 (1989-02-01), Wallace et al.
patent: 4865602 (1989-11-01), Smestad et al.
patent: 4950483 (1990-08-01), Ksander et al.
patent: 4959213 (1990-09-01), Brod et al.
patent: 5035715 (1991-07-01), Smestad et al.
patent: 5108436 (1992-04-01), Chu et al.
Am. J. Ontology, vol. 11, issued Jan. 1990, Huang et al, "A Morphometric Study of the Effects of Pressure . . . ", pp. 39-43.
Joussen, K. "Initial Experiences with Collagen . . . ", vol. 35 No. 7, pp. 291-295 (translation not available).
Wallace, et al., "Injectable cross-linked collagen with improved flow properties", Journal of Biomedical Materials Research, vol. 23, 931-945 (1989).
Skorman, Steven E., "Use of Injectable Collagen to Treat Chronic Diabetic Foot Ulcers", The Journal of Foot Surgery, vol. 26, 511-515 (1987).
McPherson, John M., et al., "The Influence of Heparin on the Wound Healing Response to Collagen Implants in vivo", Collagen Rel. Res., vol. 1, 83-100 (1988).
McPherson, John M., et al., "The Effects of Heparin on the Physicochemical Properties of Reconstituted Collagen", Collagen Rel. Res., vol. 1, 65-82 (1988).
DeLustro, Frank, Ph.D., et al. "Immune Responses to Allogeneic and Xenogeneic Implants of Collagen and Collagen Derivatives", Clinical Orthopaedics and Related Research, Section III: Basic Science and Pathology, vol. 260, 263-279 (Nov. 1990).
Cahill, Kenneth V., M.D., and John A. Burns, M.D., "Volume Augmentation of the Anophthalmic Orbit With Cross-linked Collagen (Zyplast)", Arch Ophthalmol, vol. 107, 1684-1687 (Nov. 1989).
Symmers, W. St. C., Sen. M.D., "Silicon Mastitis in `Topless` Waitresses and Some Other Varieties of Foreign-body Mastitis", Br. med. J. vol. 3, 19-22 (1968).
Trentham, David E., M.D., "Adverse Reactions to Bovine Collagen Implants: Additional Evidence for Immune Response Gene Control of Collagen Reactivity in Humans", Arch Dermatol, vol. 122, 643-644 (Jun. 1986).
Ersek, Robert A., M.D., F.A.C.S. and Arthur A. Beisand, III, M.D., "Bioplastique.TM.: A New Biphasic Polymer for Minimally Invasive Injection Implantation", Aesth. Plast. Surg., vol. 16, 59-65 (1992).
Prime, Frederick, Jr., M.D., "The Prevention of Postoperative Adhesions Between the Cortex and Dura", Univ. Penn. Med. Bull., vol. 22, 57-61 (1909).
Chao, Yi-Cheng, M.D., Storer Humphreys, M.D., and Wilder Penfield, M.D., D.Sc., "A New Method of Preventing Adhesions: The Use of Amnioplastin After Craniotomy", Br. med. J., vol. 1, 517-519 (1940).
Moscona, R., M.D., et al., "Free-Fat Injections for the Correction of Hemifacial Atrophy", Plast. Reconstr. Surg., vol. 84(3), 501-507 (1989).
"Collagen Wins Court Case Filed by Woman Claiming Treatments Are Defective", Collagen Corporation News Release, UPI, Oct. 16, 1991.
Spira, Melvin, M.D., and Theodore Rosen, MD, "Injectable Soft Tissue Substitutes", Derm. for Plast. Surg., vol. 20(1), 181-188 (1993).
Blanchard Cheryl R.
Lankford, Jr. James
Smith Robert A.
Russel Jeffrey E.
Smith Robert Allen
LandOfFree
Nonantigenic keratinous protein material does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nonantigenic keratinous protein material, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nonantigenic keratinous protein material will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-135453